Gala vs MEDGm: Which GLP-1 Provider Is Better?
Short answer: Gala scores higher on our rubric, 7.2/10 against 2.7/10. Full reasoning, pricing and the cases where the other one wins are below.
Gala beats MEDGm overall, scoring 7.2/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; MEDGm is $179 first month, rises after. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging. Choose MEDGm for shoppers who want a compounded glp-1 with the price visible before intake, and who can live with a program that names its pharmacies and its medical group but not a single prescribing clinician.
A side-by-side look at Gala and MEDGm to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Gala
#30 of 54Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.
Visit GalaMEDGm
#53 of 54MEDGm is a telehealth company selling compounded GLP-1 injections from $179 a month and dissolvable tablets from $249 a month, with Zepbound, Wegovy and Ozempic advertised on the same page as a $99 or $171 membership plus a medication cost the site never publishes. The compounded prices are readable before intake, the not-FDA-approved disclosure is prominent, the four partner pharmacies are named with street addresses in the terms, and the medical group behind the prescribing is named as OpenLoop Health. The problem is consistency. The site calls $179 all-inclusive of the first month of medication in one place and membership plus cost in another, it advertises HSA and FSA eligibility on the GLP-1 page while its terms disclaim any guarantee of it, and the three brand rows have no product page and no total.
Visit MEDGm| Feature | Gala | MEDGm |
|---|---|---|
| Why each one | A free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling. | Publishes its compounded prices before intake and names all four of its partner pharmacies with street addresses. Both are low bars that a surprising number of programs fail. |
| Our Score | 7.2/10 | 2.7/10 |
| Headline Price | from $149/mo | $179 first month, rises after |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Patients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging | Shoppers who want a compounded GLP-1 with the price visible before intake, and who can live with a program that names its pharmacies and its medical group but not a single prescribing clinician. |
| Watch out for | Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line. | MEDGm answers the price question two ways. Its FAQ calls $179 an all-inclusive price covering your first month of medication, while the Zepbound, Wegovy and Ozempic cards on the same page read $99 or $171 membership plus a medication cost the site never publishes. |
| Ranking | #30 | #53 |
| Get started | Visit Gala | Visit MEDGm |
Pros & Cons Compared
Gala
Pros
- +Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
- +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
- −Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
MEDGm
Pros
- +Compounded prices visible on the landing page without starting an intake
- +Prominent, correctly-worded disclosure that compounded GLP-1s are not FDA-approved
- +Cancel any time, with a published refund policy rather than a buried one
- +Names its four partner pharmacies in the terms, with street addresses and phone numbers, which most compounded programs never do
- +Names OpenLoop Health as the medical group behind the prescribing, and includes shipping at every tier
Cons
- −MEDGm answers the price question two ways. Its FAQ calls $179 an all-inclusive price covering your first month of medication, while the Zepbound, Wegovy and Ozempic cards on the same page read $99 or $171 membership plus a medication cost the site never publishes.
- −Zepbound, Wegovy and Ozempic are advertised as three price cards and nothing else: no product page, no total, and a trademark notice in the terms saying MEDGm is not affiliated with, endorsed by or sponsored by any brand-name manufacturer.
- −The GLP-1 page says purchases are eligible for HSA and FSA payments, while the terms say the company is cash-pay only and does not guarantee that any amount paid is eligible for reimbursement by insurance, HSA, FSA or any other benefit account.
- −No lab panel is included or priced at any tier, though the terms and the telehealth consent both allow a provider to require labs or an at-home diagnostic test before enrollment is finalized.
- −The homepage claims 120,000+ patients and the GLP-1 page badges +20k verified reviews, on a domain registered in April 2026. The footer also states that images representing testimonials may use models or artificial intelligence.
- −A prepaid contracted term is non-refundable, and dispensed medication is never refundable
- −The footer shows a LegitScript Certified seal, and the LegitScript registry returned no certification result for medgm.org when checked 2026-09-03. No third-party rating we could locate and verify exists either.
Our Verdict
Gala edges out MEDGm with a score of 7.2/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; MEDGm is $179 first month, rises after. Gala offers both brand-name and compounded medications, giving you more flexibility.
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both Gala and MEDGm start above the cheapest complete recurring program we track. Across all 54 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Gala and MEDGm.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Gala and Elevate Healthfrom $158/mo
- Compare Gala and Lemonaid Healthpublished $129/mo; total not verified
- Compare Gala and Eden Health GLP-1$99/mo month-to-month
- Compare MEDGm and TrimRxpublished $149/mo; total not verified
- Compare MEDGm and MEDVi$179 first month, then $299/mo
- Compare MEDGm and bmiMDfrom $159/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Gala legit, with the verification evidence behind each answer.
Our pick of these two: Gala · 7.2/10